Blog

The pharmaceutical landscape is considered an area where major scientific advances have been made in developing new therapies and medicines to help patients.  While much of the success achieved in pharmaceuticals is important for recognition, there is also another aspect to pharma.  That of the strategic decisions/collaboration made throughout the entire process of transforming a…

The pharmaceutical sector is in an age characterized by speed, precision, regulatory complexity, and global competition. To remain competitive, organizations face increasing pressure to bring new therapies to market more quickly while also preserving the highest level of quality, compliance, and patient safety. In this environment, organizations achieve success through not only scientific breakthroughs but...

Usually, when people recount the successes of the pharmaceutical industry, they tend to focus only on the scientific creativity, groundbreaking therapies, and the overall transformative nature of those things. However, behind each successful launch of an innovative new drug, there's always an extremely complex operational framework that determines how efficiently, compliantly, and competitively the potential...

The pharmaceutical arena is evolving similarly to the development of new medicines as companies implement better, streamlined processes to optimise sourcing, adherence to regulatory requirements, manufacturing and global distribution; all of which make them more competitive in a constantly changing business environment. Profitably harnessing the three pillars that are rapidly redefining the pharmaceutical sector, comparator...

The pharmaceutical industry has traditionally been a delicate balancing act between innovation, regulation, cost, and time. Yet today, this delicate balance has become unimaginable in its complexity. Rising research and development costs, increased compliance costs, growing global sourcing, and the need for faster time-to-market have prompted companies to rethink their traditional ways of doing business...

Modern-day pharmaceutical businesses are no longer solely defined by innovation through discovery, as success will depend on execution, or the speed, efficiency, ethics, and intelligence of moving from initial concept through to patient treatment. While innovation continues to push the boundaries of science, the operations that underpin clinical development have become just as critical to...

Innovations in medicine, such as new therapies and personalised medicine, are frequently noted as reasons for success in the pharmaceutical industry; however, behind every successful pharmaceutical product launch lies a wide-ranging set of interconnected activities, processes, and strategies, which are often not recognised when looking at successful pharmaceuticals. The pharmaceutical industry is a very complex...

Pharmaceutical Success is no longer solely about new innovative discoveries in the laboratory; it’s also about how to effectively develop, manufacture and deliver those innovative discoveries to patients. The path from early-stage molecules through to commercial-scale therapies is complicated and increasingly requires the establishment of strong strategic partnerships. The most significant elements driving this ecosystem...

The pharmaceutical sector exists at the junction of research, regulations, and international cooperation. While the leading-edge molecules and innovative therapies take centre stage in the news, the supporting ecosystem of drug development that happens behind the scenes often goes unacknowledged. One of the most important components that is often undervalued is the comparators' supply of...

In the current pharmaceutical landscape with high stakes, clinical trials are no longer just driven by scientific discoveries. They are also influenced by logistics, regulatory agencies, global marketplace dynamics, and supply chain viability. Comparator sourcing is one of the most important and neglected parts of a modern-day clinical trial; it is the strategic function that...

For many years, the pharma industry operated on a linear method: find a molecule to make, build the factory and make it at scale. The year we are currently in has created a new paradigm. With the birth of Antibody-Drug Conjugates (ADCs), cell and gene therapies and the "patent cliff" hitting many large blockbusters, companies...

Development of a drug isn't just about scientific discovery; it's also about efficient, precise, and collaborative development. For pharmaceutical companies, a successful drug depends on many specialised network partners, including API Contract Manufacturers and full-service contract manufacturers that develop or provide APIs to meet the highest quality standards for their compounds. Additionally, pharmaceutical contract manufacturers...

Clinical research continues to accelerate at an extraordinary pace with the emergence of new therapeutic Indications, adaptive trial designs, decentralized studies, and global recruitment for clinical trials. However, amidst all the technological advances and unprecedented speed, there continues to exist one essential building block of success: obtaining the right comparator compound in the right location...